Zealand Pharma A/S (CPH:ZEAL)

Zealand Pharma Ratios and Metrics

Market cap in millions DKK. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 8, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	20,875	32,852	50,548	21,785	10,366	6,271
Market Cap Growth	-48.93%	-35.01%	132.03%	110.16%	65.31%	-28.46%
Enterprise Value	6,172	17,089	41,733	20,319	10,519	5,364
Last Close Price	295.60	466.40	715.50	373.20	201.40	145.10
PE Ratio	3.28	5.09	-	-	-	-
PS Ratio	2.27	3.57	806.30	63.55	99.69	57.77
PB Ratio	1.41	2.22	5.87	13.68	12.71	6.76
P/TBV Ratio	1.41	2.22	5.88	13.78	12.71	7.17
P/FCF Ratio	3.21	5.06	-	-	-	-
P/OCF Ratio	3.20	5.03	-	-	-	-
EV/Sales Ratio	0.67	1.86	665.70	59.28	101.16	49.41
EV/EBITDA Ratio	0.89	2.47	-	-	-	-
EV/EBIT Ratio	0.89	2.47	-	-	-	-
EV/FCF Ratio	0.95	2.63	-	-	-	-
Debt / Equity Ratio	0.03	0.03	0.05	0.08	0.64	0.85
Debt / EBITDA Ratio	0.06	0.06	-	-	-	-
Debt / FCF Ratio	0.06	0.06	-	-	-	-
Net Debt / Equity Ratio	-0.99	-0.99	-1.00	-0.95	-0.80	-0.69
Net Debt / EBITDA Ratio	-2.12	-2.12	6.88	2.73	0.90	0.83
Net Debt / FCF Ratio	-2.26	-2.26	9.20	3.47	0.69	0.52
Asset Turnover	0.72	0.72	0.01	0.20	0.06	0.06
Inventory Turnover	-	-	0.85	0.69	-	0.12
Quick Ratio	23.20	23.20	20.85	6.23	6.73	4.80
Current Ratio	23.57	23.57	21.14	6.25	6.73	5.15
Return on Equity (ROE)	55.06%	55.06%	-21.13%	-58.43%	-110.75%	-69.99%
Return on Assets (ROA)	33.97%	33.97%	-13.81%	-19.93%	-28.30%	-25.53%
Return on Invested Capital (ROIC)	-	1401.57%	-294.62%	-465.46%	-363.56%	-402.18%
Return on Capital Employed (ROCE)	45.30%	45.30%	-13.90%	-33.10%	-60.70%	-45.10%
Earnings Yield	30.92%	19.65%	-2.13%	-3.23%	-11.60%	-16.24%
FCF Yield	31.13%	19.78%	-1.86%	-2.01%	-9.20%	-19.68%
Buyback Yield / Dilution	-7.70%	-7.70%	-17.40%	-22.49%	-7.77%	-11.73%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.